Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve therapeutic reduction of {HEAD ~ the number} of {TAIL ~ circulating platelets} 
Neutrophil activating peptide 2 or analog thereof is administered to a mammal to achieve therapeutic reduction of { HEAD ~ the number } of { TAIL ~ circulating platelets }
OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD REL TAIL TAIL TAIL TAIL TAIL TAIL